These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11743284

  • 21. Prostate cancer detection by prostate-specific antigen-related parameters.
    Segawa N, Gohji K, Iwamoto Y, Ueda H, Katsuoka Y.
    Hinyokika Kiyo; 2003 Jul; 49(7):405-10. PubMed ID: 12968483
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
    Khan MA, Partin AW, Rittenhouse HG, Mikolajczyk SD, Sokoll LJ, Chan DW, Veltri RW.
    J Urol; 2003 Sep; 170(3):723-6. PubMed ID: 12913682
    [Abstract] [Full Text] [Related]

  • 23. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A.
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [Abstract] [Full Text] [Related]

  • 24. Is there a role for serum human tissue kallikrein in detection of prostate cancer?
    Ochiai A, Shukla A, Davis JW, Fritsche HA, Bhadkamkar V, Babaian RJ.
    Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108
    [Abstract] [Full Text] [Related]

  • 25. Prospective use of free PSA to avoid repeat prostate biopsies in men with elevated total PSA.
    Morgan TO, McLeod DG, Leifer ES, Moul JW, Murphy GP.
    Prostate Suppl; 1996 Sep; 7():58-63. PubMed ID: 8950365
    [Abstract] [Full Text] [Related]

  • 26. Prostate-specific antigen (PSA) complexed to alpha1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL.
    Kobayashi T, Kamoto T, Nishizawa K, Mitsumori K, Ogura K, Ide Y.
    BJU Int; 2005 Apr; 95(6):761-5. PubMed ID: 15794778
    [Abstract] [Full Text] [Related]

  • 27. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M.
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [Abstract] [Full Text] [Related]

  • 28. Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: relationship to transition zone volume.
    Stamey TA, Yemoto CE.
    J Urol; 2000 Jan; 163(1):119-26. PubMed ID: 10604328
    [Abstract] [Full Text] [Related]

  • 29. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Jan; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 30. Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection?
    Etzioni R, Falcon S, Gann PH, Kooperberg CL, Penson DF, Stampfer MJ.
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1640-5. PubMed ID: 15466981
    [Abstract] [Full Text] [Related]

  • 31. Strategies combining total and percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation.
    Gann PH, Ma J, Catalona WJ, Stampfer MJ.
    J Urol; 2002 Jun; 167(6):2427-34. PubMed ID: 11992051
    [Abstract] [Full Text] [Related]

  • 32. [Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer].
    Laguna Pes MP, Guinda Sevillano C, Zazo Romojaro A, Domínguez J, García Luzón A, Borrego Hernando J, Gimeno Collado A.
    Arch Esp Urol; 2000 May; 53(4):333-41. PubMed ID: 10900763
    [Abstract] [Full Text] [Related]

  • 33. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y, Kamei S, Nakano M, Ehara H, Deguchi T, Tanaka O.
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [Abstract] [Full Text] [Related]

  • 34. T1c prostate cancer detection rate and pathologic characteristics: comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population.
    Park HK, Hong SK, Byun SS, Lee SE.
    Urology; 2006 Jul; 68(1):85-8. PubMed ID: 16806412
    [Abstract] [Full Text] [Related]

  • 35. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
    Miyakubo M, Ito K, Yamamoto T, Takechi H, Ohi M, Suzuki K.
    Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
    [Abstract] [Full Text] [Related]

  • 36. Improved prostate cancer detection using systematic 14-core biopsy for large prostate glands with normal digital rectal examination findings.
    Inahara M, Suzuki H, Kojima S, Komiya A, Fukasawa S, Imamoto T, Naya Y, Ichikawa T.
    Urology; 2006 Oct; 68(4):815-9. PubMed ID: 17070359
    [Abstract] [Full Text] [Related]

  • 37. Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.
    Irani J, Salomon L, Soulié M, Zlotta A, de la Taille A, Doré B, Millet C.
    Urology; 2005 Mar; 65(3):533-7. PubMed ID: 15780371
    [Abstract] [Full Text] [Related]

  • 38. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
    Oliver SE, Holly J, Peters TJ, Donovan J, Persad R, Gillatt D, Pearce A, Hamdy FC, Neal DE, Gunnell D.
    Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
    [Abstract] [Full Text] [Related]

  • 39. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
    Serdar MA, Oguz O, Olgun A, Seçkin B, Ilgan S, Hasimi A, Salih M, Peker F, Kutluay T.
    Ann Clin Lab Sci; 2002 Aug; 32(1):22-30. PubMed ID: 11848613
    [Abstract] [Full Text] [Related]

  • 40. Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer.
    Finne P, Zhang WM, Auvinen A, Leinonen J, Määttänen L, Rannikko S, Tammela TL, Stenman UH.
    J Urol; 2000 Dec; 164(6):1956-60. PubMed ID: 11061890
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.